April 2024
1. KINCHIN I, Walsh S, Dinh R, Kapuwa M, et al
   Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapies.
   Br J Psychiatry. 2024 Apr 17:1-7. doi: 10.1192/bjp.2024.
   

   >> Share

   
   January 2024
2. LAURELL AAS, Venkataraman AV, Schmidt T, Montagnese M, et al
   Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK.
   Br J Psychiatry. 2024 Jan 18:1-7. doi: 10.1192/bjp.2023.
   

   >> Share

   
   November 2023
3. KUIPERS E
   Catching the threads: caregiving in Alzheimer's disease.
   Br J Psychiatry. 2023;223:507-508.
   

   >> Share

   
   August 2023
4. SMADI M, Kaburis M, Schnapper Y, Reina G, et al
   SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses.
   Br J Psychiatry. 2023;223:348-361.
   

   >> Share

   
   December 2022
5. BEBBINGTON P
   Losing the thread: experiences of cognitive decline in Alzheimer's disease.
   Br J Psychiatry. 2022 Dec 7:1-2. doi: 10.1192/bjp.2022.
   

   >> Share

   
   May 2021
6. ROBERTS G, Donaghy PC, Lloyd J, Durcan R, et al
   Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies.
   Br J Psychiatry. 2021;218:276-282.
   

   >> Share

   
   
7. VACI N, Koychev I, Kim CH, Kormilitzin A, et al
   Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study.
   Br J Psychiatry. 2021;218:261-267.
   

   >> Share

   
   November 2020
8. REEVES S, Bertrand J, Uchida H, Yoshida K, et al
   Towards safer risperidone prescribing in Alzheimer's disease.
   Br J Psychiatry. 2020 Nov 12:1-8. doi: 10.1192/bjp.2020.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share